Expressive Writing Therapy for Breast Cancer Survivors
Trial Summary
What is the purpose of this trial?
This clinical trial studies the effect of a culturally based brief expressive writing intervention in improving the health of Chinese immigrant stage 0-III breast cancer survivors. Culturally based brief expressive writing interventions may help researchers learn more about the experiences of Chinese immigrant breast cancer survivors and how writing about their experiences may affect their health.
Do I need to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on expressive writing therapy for breast cancer survivors.
What data supports the effectiveness of the treatment Culturally Based Brief Expressive Writing Intervention for breast cancer survivors?
Research shows that expressive writing can improve quality of life and self-care abilities in breast cancer patients, with studies indicating benefits like better physical and mental health. These effects have been observed in various cultural contexts, including among Chinese breast cancer patients.12345
Is expressive writing therapy safe for breast cancer survivors?
How is the Expressive Writing Therapy treatment different from other treatments for breast cancer survivors?
Expressive Writing Therapy is unique because it focuses on allowing breast cancer survivors to express their deepest thoughts and feelings about their experiences through writing, which can improve their quality of life and self-care abilities. Unlike traditional medical treatments, this therapy is a psychological intervention that helps patients process emotions and adapt cognitively to their condition.12356
Research Team
Qian Lu, MD
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for foreign-born Chinese women, aged 18 or older, who have been living in the U.S. for at least six months and were diagnosed with stage 0-III breast cancer. Participants should have completed primary treatments like surgery or chemotherapy within the last five years.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in expressive writing sessions, writing about their cancer experiences for 3 weekly 30-minute sessions
Follow-up
Participants are monitored for quality of life and stress biomarkers at 6 weeks, 6 months, and 12 months
Treatment Details
Interventions
- Culturally Based Brief Expressive Writing Intervention
Culturally Based Brief Expressive Writing Intervention is already approved in United States for the following indications:
- Improvement of health in Chinese immigrant stage 0-III breast cancer survivors
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator